|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 05, 2012 ) New York, NY -- Shares of Titan Pharmaceuticals (TTNP) could be positioned to run, according to VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors.
Strong Thursday volume for Titan shares follows a few days of increasing volume, a key indicator that the share price may be building for an increase as the company prepares to file with the FDA for the approval of Probuphine, a treatment for opioid addiction that successfully completed Phase III trials.
For full Titan Pharmaceuticals update visit: http://vfcsstockhouse.com/blog/article/-volume-watch-titan-pharmaceuticals-shares-picking-up-the-trading-pace
Still a potential growth story based on a few recently realized developments, Teletouch Communications (TLLE) continues to trade under the radar while solidifying its redirected business plan that heavily emphasizes distribution and hardware sales, mainly through the company's primary subsidiary.
The refocused plan was met with early success.
Multiple new distribution agreements were announced last month, a key indication that Teletouch is making headway in securing a dominating presence in the distribution channels of several well-known brands, such as AT&T (T). Also noteworthy to the Teletouch bottom line was settled litigation with T that brought in over $18 million dollars, not a small sum for a still-growing company. The litigation related to certain hardware that the telecom giant was not allowing Teletouch to sell through its channels, but as a result of the settlement the two entities agreed upon another multi-year contract that - since they also agreed to forgo any further litigation - should keep the marriage well intact.
For full update on Teletouch Communications visit: http://vfcsstockhouse.com/blog/article/-teletouch-communications-still-slipping-below-the-radar
For this week's list of hot stocks to watch visit: http://vfcsstockhouse.com/blog/article/-weekly-stock-watch-week-of-1-july-celh-imsc-pbth-teva-lptn-mric-bsx-si-amrn-ssh-arna-bdsi-avnr-sppi-onty-tlle
Contact VFC's Stock House: vfc@vfcsstockhouse.com
Originally published at: http://vfcsstockhouse.com
Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse
'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213
About VFCsStockHouse.com:
VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks, biopharma stocks, growth stocks and the pharmaceutical and healthcare sectors. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights into broader-market news through various 'Stock Watch' lists. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies.
For full disclaimer visit: http://vfcsstockhouse.com
VFC's Stock House
VFC
240-786-2111
vfc@vfcsstockhouse.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
